CD34 and leukemia: To our knowledge, the present study is the first to demonstrate that ULK1 inhibitors effectively induce mitochondria-mediated, caspase-dependent apoptosis in FLT3-ITD-mutated leukemia cell lines and primary leukemia cells, but not in normal CD34 (+) cells.